SCH: INT: Collaborative Research: Assistive Integrative Support Tool for Retinopathy of Prematurity

Information

  • NSF Award
  • 1622542
Owner
  • Award Id
    1622542
  • Award Effective Date
    10/1/2016 - 8 years ago
  • Award Expiration Date
    9/30/2020 - 4 years ago
  • Award Amount
    $ 688,207.00
  • Award Instrument
    Standard Grant

SCH: INT: Collaborative Research: Assistive Integrative Support Tool for Retinopathy of Prematurity

Retinopathy of prematurity (ROP) is a leading cause of childhood visual loss worldwide, and the social burdens of infancy-acquired blindness are enormous. Early diagnosis is critically important for successful treatment, and can prevent most cases of blindness. However, lack of access to expert medical diagnosis and care, especially in rural areas, remains a growing healthcare challenge. In addition, clinical expertise in ROP is lacking, and medical professionals are struggling to meet the increasing need for ROP care. As point-of-care technologies for diagnosis and intervention are rapidly expanding, the potential ability to assess ROP severity from any location with an internet connection and a camera, even without immediate ophthalmologic consultation available, could significantly improve delivery of ROP care by identifying infants who are in most urgent need for referral and treatment. This would dramatically reduce the incidence of blindness without a proportionate increase in the need for human resources, which take many years to develop.<br/><br/>This project develops a prototype assistive integrative support tool for ROP, featuring a modular design comprising: (a) image analysis, (b) information fusion of clinical, imaging, and diagnostic data, and (c) generative probabilistic and regression models with associated computationally efficient machine learning algorithms. The outcomes of the project include disease severity metrics and diagnostic estimates obtained through clinical evidence classifiers trained jointly over expert-generated labels. These labels consist of discrete diagnostic labels, as well as comparison outcomes of relative severity between pairs of images. Random process models for vessel tortuosity and diameter distributions over the retina, as well as patch-based vessel-free image analysis through the use of convolutional neural networks on the entire image, enhance and augment feature extraction. Moreover, incorporating severity comparison outcomes through novel hard and soft constraint methods force inferred severity to agree with ordinal information provided by experts and address inherent uncertainty in expert ground-truth labels. The above severity inference methods are evaluated and fine-tuned over a broad array of generative models, both through retrospective analysis, including cross-validation, longitudinal tests, and tests across multiple sites, as well as through prospective analysis, evaluating its real-world clinical impact.

  • Program Officer
    Aidong Zhang
  • Min Amd Letter Date
    7/27/2016 - 8 years ago
  • Max Amd Letter Date
    7/27/2016 - 8 years ago
  • ARRA Amount

Institutions

  • Name
    Massachusetts General Hospital
  • City
    Boston
  • State
    MA
  • Country
    United States
  • Address
    Research Management
  • Postal Code
    021142621
  • Phone Number
    8572821670

Investigators

  • First Name
    Jayashree
  • Last Name
    Kalpathy-Cramer
  • Email Address
    kalpathy@nmr.mgh.harvard.edu
  • Start Date
    7/27/2016 12:00:00 AM

Program Element

  • Text
    Smart and Connected Health
  • Code
    8018

Program Reference

  • Text
    Smart and Connected Health
  • Code
    8018
  • Text
    SCH Type II: INT
  • Code
    8062